In-hospital mortality of status epilepticus in China: Results from a nationwide survey
In-hospital mortality of status epilepticus in China: Results from a nationwide survey
复制标题
中国癫痫持续状态的院内死亡率：全国调查结果
DOI：
10.1016/j.seizure.2019.11.006
复制
发表时间：
2020-02-01
影响因子：
3
通讯作者：
Zhou, Dong
中科院分区：
文献类型：
--
作者：
Lu, Lu;Xiong, Weixi;Zhou, Dong
目的：我们试图确定全国范围内癫痫持续状态（SE）患者的住院死亡率在China.Methods：使用中国医院质量监测系统（HQMS）的数据库，我们确定了2013年至2017年住院的人与ICD-10编码G41的SE作为主要诊断。HQMS由中华人民共和国国家卫生健康委员会制定。人口统计学，出院时的结果，和财务信息自动提取的医疗records.Results：我们确定了29,031例SE作为主要诊断从585个三级中心在五年期间。在纳入的患者中，男性占优势（61%），平均年龄为40.4 ± 25.2岁（范围：0-98岁）。整个时间段的住院死亡率为1.46%，而总体死亡率范围从2013年的1.80%到2017年的1.20%。平均治疗费用为14517.81元人民币（2147.92美元），平均住院时间为9.25 day.Conclusion：我们提供了一个概述的死亡率相关的SE在中国的HQMS数据库涵盖了大量的情况下，SE在中国，使其成为最有效的工具之一，死亡率调查。电子病历在中国的使用带来了一些挑战，在这里我们讨论一下经验教训。该方法将得到改进并将用于未来的研究。
Purpose: We attempted to determine the nationwide in-hospital mortality rate in people with status epilepticus (SE) in China.Methods: Using the database of the Chinese Hospital Quality Monitoring System (HQMS), we identified people hospitalised from 2013 to 2017 with an ICD-10 code G41 for SE as the primary diagnosis. HQMS was developed by the National Health Commission of the People's Republic of China. Demographics, outcomes at discharge, and financial information were extracted automatically from the medical records.Results: We identified 29,031 cases with SE as the primary diagnosis from 585 tertiary centres during the five-year period. Among those included, there was a preponderance of men (61 %), and the mean age was 40.4 +/- 25.2 years (range: 0-98). The in-hospital mortality rate was 1.46 % over the whole time period, while the overall mortality ranged from 1.80 % in 2013 to 1.20 % in 2017. The mean cost of treatment was 14517.81 RMB ($ 2147.92) per individual, and the mean duration of hospital stay was 9.25 days.Conclusion: We provide an overview of mortality related to SE in China as the HQMS database covers a large number of cases of SE in China, making it one of the most efficient tools for mortality investigation. The use of electronic medical records in China creates several challenges and here we discuss lessons learned. The methodology will be improved and will be used in future studies.